Filtros : "Clinical Pharmacology and Therapeutics" Limpar

Filtros



Refine with date range


  • Source: Clinical Pharmacology and Therapeutics. Unidades: FCFRP, FMRP

    Subjects: FARMACOCINÉTICA CLÍNICA, PLACENTA, ANTIDEPRESSIVOS, GESTANTES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CARVALHO, Daniela Miarelli et al. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, v. 105, n. 4, p. 1003-1008, 2019Tradução . . Disponível em: https://doi.org/10.1002/cpt.1263. Acesso em: 23 maio 2024.
    • APA

      Carvalho, D. M., Lanchote, V. L., Filgueira, G. C. de O., Nardotto, G. H. B., Duarte, G., Cavalli, R. C., & Moisés, E. C. D. (2019). Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, 105( 4), 1003-1008. doi:10.1002/cpt.1263
    • NLM

      Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 maio 23 ] Available from: https://doi.org/10.1002/cpt.1263
    • Vancouver

      Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 maio 23 ] Available from: https://doi.org/10.1002/cpt.1263
  • Source: Clinical Pharmacology and Therapeutics. Unidade: FM

    Assunto: ENDOCRINOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FARIA, S R G F L et al. Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension. Clinical Pharmacology and Therapeutics, v. 44, n. 6 , p. 670-4, 1988Tradução . . Disponível em: https://doi.org/10.1038/clpt.1988.210. Acesso em: 23 maio 2024.
    • APA

      Faria, S. R. G. F. L., Zanella, M. T., Andriolo, A., Ribeiro, A. B., & Chacra, A. R. (1988). Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension. Clinical Pharmacology and Therapeutics, 44( 6 ), 670-4. doi:10.1038/clpt.1988.210
    • NLM

      Faria SRGFL, Zanella MT, Andriolo A, Ribeiro AB, Chacra AR. Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension [Internet]. Clinical Pharmacology and Therapeutics. 1988 ;44( 6 ): 670-4.[citado 2024 maio 23 ] Available from: https://doi.org/10.1038/clpt.1988.210
    • Vancouver

      Faria SRGFL, Zanella MT, Andriolo A, Ribeiro AB, Chacra AR. Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension [Internet]. Clinical Pharmacology and Therapeutics. 1988 ;44( 6 ): 670-4.[citado 2024 maio 23 ] Available from: https://doi.org/10.1038/clpt.1988.210

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024